Yahoo Web Search

Search results

  1. Dr. Moskowitz is Co-director of the International Center for Health Outcomes and Innovation Research (InCHOIR), with over 15 years of experience in directing both clinical and data coordinating centers for multicenter clinical trials, both NIH and industry sponsored.

    • Icahn (East) Building Floor 2nd Floor Room L2-44, 1425 Madison Ave, New York, 10029, NY
    • (212) 659-9567
  2. May 7, 2024 · He currently directs the data coordinating center for the NINDS sponsored ARUBA trial (70 clinical centers worldwide) comparing watchful waiting to immediate intervention for patients with unruptured brain AVMS. Dr. Moskowitz has been in the leadership team for the NHLBI support Cardiothoracic Surgical Trials Network (CTSN) to which he brings ...

  3. Alan MOSKOWITZ, Professor (Full) | Cited by 18,848 | of Icahn School of Medicine at Mount Sinai, New York (MSSM) | Read 191 publications | Contact Alan MOSKOWITZ

  4. Vice-Chair & Professor Population Health Science & Policy: Professor of Medicine · Experience: Icahn School of Medicine at Mount Sinai · Education: Tufts University School of Medicine ...

    • 181
    • Icahn School of Medicine at Mount Sinai
    • Brown University-The Miriam Hospital
    • 181
  5. Jan 28, 2016 · Conclusions: In patients undergoing mitral-valve repair or replacement for severe ischemic mitral regurgitation, we observed no significant between-group difference in left ventricular reverse remodeling or survival at 2 years.

    • Robert E. Michler, Peter K. Smith, Michael K. Parides, Gorav Ailawadi, Vinod Thourani, Alan J. Mosko...
    • 2016
  6. View Alan Moskowitzs profile on LinkedIn, a professional community of 1 billion members.

    • Xperi Corporation
  7. Apr 10, 2020 · Under the leadership of Annetine Gelijns, PhD, Alan Moskowitz, MD, and Emilia Bagiella, PhD, of Mount Sinai’s Institute of Transformative Clinical Trials, Mount Sinai will serve as the clinical and data coordinating center for a randomized clinical trial evaluating the therapeutic benefit and safety of this stem cell therapy in 240 ...